Menu
close
Please contact us for more information or to learn if you are eligible to participate.
The main purpose of this study is to investigate the effectiveness and safety of rencofilstat at different dose levels in subjects who have been diagnosed with NASH and advanced fibrosis
Principal Investigator | Henry Herrera, MD |
Co-PI | Hiram Garcia Jr. |
Sponsor | Hepion Pharmaceuticals, Inc. |
Type of Trial | Interventional |